Back
Aquestive Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
63
AQST
Aquestive Therapeutics
Last Price:
5.15
Seasonality Move:
-3.4%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is moderately bearish and AQST is experiencing selling pressure, which indicates risk of future bearish movement.
Aquestive Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.49 | Sell |
| 20-day SMA: | 5.16 | Sell |
| 50-day SMA: | 4.89 | Buy |
| 200-day SMA: | 3.78 | Buy |
| 8-day EMA: | 5.39 | Sell |
| 20-day EMA: | 5.23 | Sell |
| 50-day EMA: | 4.84 | Buy |
| 200-day EMA: | 3.78 | Buy |
Aquestive Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 50.39 | Buy |
| Chaikin Money Flow: | -1600841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.78 - 5.4) | Buy |
| Bollinger Bands (100): | (3.01 - 5.03) | Buy |
Aquestive Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aquestive Therapeutics Stock
Is Aquestive Therapeutics Stock a Buy?
- Aquestive Therapeutics share price is 5.15 while AQST 8-day simple moving average is 5.49, which is a Sell signal.
- The stock price of AQST is 5.15 while Aquestive Therapeutics 20-day SMA is 5.16, which makes it a Sell.
- Aquestive Therapeutics 50-day simple moving average is 4.89 while AQST share price is 5.15, making it a Buy technically.
- AQST stock price is 5.15 and Aquestive Therapeutics 200-day simple moving average is 3.78, creating a Buy signal.
AQST Technical Analysis vs Fundamental Analysis
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy or a Sell?
-
Aquestive Therapeutics stock is rated a Buy
The current Aquestive Therapeutics [AQST] share price is $5.15. The Score for AQST is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Aquestive Therapeutics Stock Info
Market Cap:
468.96M
Price in USD:
5.15
Share Volume:
1.88M
Aquestive Therapeutics 52-Week Range
52-Week High:
6.23
52-Week Low:
1.48
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Aquestive Therapeutics Share Price Forecast
-
What is the Aquestive Therapeutics stock price today?
The Aquestive Therapeutics stock price is 5.15 USD today. -
Will AQST stock go up or go down?
Aquestive Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aquestive Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aquestive Therapeutics is not overvalued.
Is Aquestive Therapeutics Stock a Buy?
- Aquestive Therapeutics share price is 5.15 while AQST 8-day exponential moving average is 5.39, which is a Sell signal.
- The stock price of AQST is 5.15 while Aquestive Therapeutics 20-day EMA is 5.23, which makes it a Sell.
- Aquestive Therapeutics 50-day exponential moving average is 4.84 while AQST share price is 5.15, making it a Buy technically.
- AQST stock price is 5.15 and Aquestive Therapeutics 200-day simple moving average is 3.78, creating a Buy signal.
Fundamental Analysis of Aquestive Therapeutics
Is Aquestive Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Aquestive Therapeutics
Should I short Aquestive Therapeutics stock?
- AQST Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Aquestive Therapeutics is a Buy
- Aquestive Therapeutics Relative Strength Index (RSI) is 50.39, which suggest Aquestive Therapeutics is overbought
- The Bollinger Bands (25) for Aquestive Therapeutics is (4.78 - 5.4), which suggest Aquestive Therapeutics is a Buy
- The Bollinger Bands (100) for Aquestive Therapeutics is (3.01 - 5.03), which suggest Aquestive Therapeutics is a Buy
* Aquestive Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.